Related Experiment Videos
Genetic dissection of melanoma pathways in the mouse
1Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Mayer 448, Boston, MA 02115, USA.
Abstract:
The frequent loss of the INK4a/ARF locus, encoding for both p16(INK4a)and p19(ARF)in human melanoma, raises the question as to which INK4a/ARF gene product functions to suppress melanoma-genesis in vivo. Studies in the mouse have shown that activated RAS mutation can cooperate with INK4a(Delta 2/3)deficiency (null for both p16(INK4a)and p19(ARF)) to promote development of melanoma, and these melanomas retain wild-type p53. Given the functional link between p19(ARF)and p53, we have now shown that activated RAS can also cooperate with p53 deficiency to produce melanoma in the mouse. Moreover, genome-wide analysis of RAS-induced p53 mutant melanomas reveals alterations of key components governing RB-regulated G1/S transition, such as c-Myc. These experimental findings suggest that both RB and p53 pathways function to suppress melanocyte transformation in vivo in the mouse.
Insights
Loss of INK4a/ARF genes contributes to melanoma. Research shows both RB and p53 pathways suppress melanocyte transformation, crucial for understanding melanoma development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The INK4a/ARF locus, encoding p16(INK4a) and p19(ARF), is frequently lost in human melanoma.
- Understanding which INK4a/ARF gene product suppresses melanoma in vivo is critical.
Purpose of the Study:
- To investigate the roles of p16(INK4a) and p19(ARF) in melanoma suppression.
- To determine if p53 deficiency cooperates with RAS mutation in melanoma development.
Main Methods:
- Mouse models with activated RAS mutation and INK4a(Delta 2/3) deficiency were studied.
- RAS-induced p53 mutant melanomas underwent genome-wide analysis.
Main Results:
- Activated RAS cooperates with INK4a deficiency to promote melanoma in mice.
- Activated RAS also cooperates with p53 deficiency to induce melanoma.
- Alterations in RB-regulated G1/S transition components like c-Myc were observed in p53 mutant melanomas.
Conclusions:
- Both RB and p53 pathways are essential for suppressing melanocyte transformation in vivo.
- These findings highlight the complex genetic landscape of melanoma development.